BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34721946)

  • 1. Spatial heterogeneity of immune infiltration predicts the prognosis of nasopharyngeal carcinoma patients.
    Wang YQ; Liu X; Xu C; Jiang W; Xu SY; Zhang Y; Liang YL; Li JY; Li Q; Chen YP; Zhao Y; Yun JP; Liu N; Li YQ; Ma J
    Oncoimmunology; 2021; 10(1):1976439. PubMed ID: 34721946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma.
    Li J; Jiang R; Liu WS; Liu Q; Xu M; Feng QS; Chen LZ; Bei JX; Chen MY; Zeng YX
    PLoS One; 2013; 8(12):e83069. PubMed ID: 24386144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of immune score in nasopharyngeal carcinoma using digital pathology.
    Wang YQ; Chen L; Mao YP; Li YQ; Jiang W; Xu SY; Zhang Y; Chen YP; Li XM; He QM; He SW; Yang XJ; Lei Y; Zhao Y; Yun JP; Liu N; Li Y; Ma J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32690665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of tumor-infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large-scale cohort study.
    Wang YQ; Chen YP; Zhang Y; Jiang W; Liu N; Yun JP; Sun Y; He QM; Tang XR; Wen X; Yang XJ; Zhang PP; Zhang J; Lei Y; Li YQ; Ma J
    Int J Cancer; 2018 Jun; 142(12):2558-2566. PubMed ID: 29377121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD3+T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma.
    Al-Rajhi N; Soudy H; Ahmed SA; Elhassan T; Mohammed SF; Khoja HA; Ghebeh H
    BMC Cancer; 2020 Mar; 20(1):240. PubMed ID: 32199452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic effect of parotid area lymph node metastases after preliminary diagnosis of nasopharyngeal carcinoma: a propensity score matching study.
    Xu Y; Chen X; Zhang M; Xiao Y; Zong J; Guo Q; Qiu S; Zheng W; Lin S; Pan J
    Cancer Med; 2017 Oct; 6(10):2213-2221. PubMed ID: 28879654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of prognostic nutritional index in nasopharyngeal carcinoma: A meta-analysis containing 4511 patients.
    Tu X; Ren J; Zhao Y
    Oral Oncol; 2020 Nov; 110():104991. PubMed ID: 32919361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis.
    Yang L; Xia L; Wang Y; Hong S; Chen H; Liang S; Peng P; Chen Y
    PLoS One; 2016; 11(7):e0158853. PubMed ID: 27399281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-treatment amide proton transfer imaging predicts treatment outcome in nasopharyngeal carcinoma.
    Qamar S; King AD; Ai QH; Mo FKF; Chen W; Poon DMC; Tong M; Ma BB; Yeung DK; Wang YX; Yuan J
    Eur Radiol; 2020 Nov; 30(11):6339-6347. PubMed ID: 32588210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients.
    Jiang R; Zou X; Hu W; Fan YY; Yan Y; Zhang MX; You R; Sun R; Luo DH; Chen QY; Huang PY; Hua YJ; Guo L; Chen MY
    Tumour Biol; 2015 Sep; 36(10):7775-87. PubMed ID: 25944165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment interleukin 6 and clinical stage.
    Ke L; Xiang Y; Xia W; Yang J; Yu Y; Ye Y; Liang H; Guo X; Lv X
    Clin Immunol; 2016 Mar; 164():45-51. PubMed ID: 26780676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of serum bilirubin in southern Chinese patients with advanced nasopharyngeal carcinoma.
    Yao JJ; Kou J; Peng QH; Dong J; Zhang WJ; Lawrence WR; Zhang F; Zhou GQ; Wang SY; Sun Y
    Clin Chim Acta; 2018 Sep; 484():314-319. PubMed ID: 29860034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma.
    Wang J; Li L; Dong BQ; Xu YJ; Zheng YD; Sun ZW; Yang Y; Chen YY; Chen XZ; Chen M
    Oncotarget; 2016 May; 7(19):27458-67. PubMed ID: 27050275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Plasma Epstein-Barr Virus DNA for Local and Regionally Advanced Nasopharyngeal Carcinoma Treated With Cisplatin-Based Concurrent Chemoradiotherapy in Intensity-Modulated Radiotherapy Era.
    Chen WH; Tang LQ; Guo SS; Chen QY; Zhang L; Liu LT; Qian CN; Guo X; Xie D; Zeng MS; Mai HQ
    Medicine (Baltimore); 2016 Feb; 95(5):e2642. PubMed ID: 26844482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma.
    Ooft ML; van Ipenburg JA; Sanders ME; Kranendonk M; Hofland I; de Bree R; Koljenović S; Willems SM
    J Clin Pathol; 2018 Mar; 71(3):267-274. PubMed ID: 28877959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients.
    Liu LT; Chen QY; Tang LQ; Guo SS; Guo L; Mo HY; Chen MY; Zhao C; Guo X; Qian CN; Zeng MS; Bei JX; Tan J; Chen S; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
    Cancer Res Treat; 2018 Jan; 50(1):19-29. PubMed ID: 28392551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
    Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
    Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of spatial heterogeneity of tumor microenvironment in nasopharyngeal carcinoma via transcriptional digital spatial profiling.
    Wang L; Wang D; Zeng X; Zhang Q; Wu H; Liu J; Wang Y; Liu G; Pan Y
    Int J Biol Sci; 2023; 19(7):2256-2269. PubMed ID: 37151882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma.
    Jiang W; Liu N; Chen XZ; Sun Y; Li B; Ren XY; Qin WF; Jiang N; Xu YF; Li YQ; Ren J; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Mai HQ; Zeng MS; Kang TB; Jia WH; Shao JY; Ma J
    Mol Cancer Ther; 2015 Dec; 14(12):2864-73. PubMed ID: 26443805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
    Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
    Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.